Nearly after a year and a half, the Chinese authorities have released their verdict for GlaxoSmithKline plc (ADR) (NYSE:GSK), which was accused of bribing doctors to use their medicines. GlaxoSmithKline plc (ADR) (NYSE:GSK) would have to pay fines amounting to £297 million or $489 million to the Chinese government. The state news agency, Xinhua, further…
GlaxoSmithKline plc (ADR) (GSK) Might Face Legal Trouble in Chinese Consumer Healthcare Unit
GlaxoSmithKline plc (ADR) (NYSE:GSK) could be involved in breaking an anti-bribery law in its Chinese consumer healthcare unit and the probe might raise some legal concerns for the company. GlaxoSmithKline plc (ADR) (NYSE:GSK) faced a U.S. anti-bribery inquiry in 2012, as indicated in its internal documents. Further, even the company did an internal investigation to…
GlaxoSmithKline plc (ADR) (GSK) Vaccine for Ebola Exhibits Positive Results in Monkey Tests
With Ebola affecting a vast population in West Africa, there is some good news from GlaxoSmithKline plc (ADR) (NYSE:GSK) as it has successfully tested its Ebola Vaccine on Monkeys. The test included monkeys with Ebola infection and after giving the experimental drug, the monkey didn’t develop any signs of the deadly virus. As per the…